OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Jinglian Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal and Anal Disease Unit, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, No.71 Hedi Road, Nanning 530021…. Hauptthemen laut MEDLINE: Ferroptosis, Phospholipid Hydroperoxide Glutathione Peroxidase, Autophagy, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis, a regulated cell demise predicated on iron metabolism and lipid peroxidation, has increasingly become a focal point in oncological therapies. Nonetheless, its governance, particularly the role of deubiquitination, is not fully delineated. This investigation concentrates on the deubiquitinase OTUD4, scrutinizing its functional and molecular implications in ferroptosis within tumor cells. By engineering OTUD4 knockout cell lines via CRISPR-Cas9, we observed that these cells exhibit heightened sensitivity to ferroptosis inducers, augmenting ferroptotic cell death and robustly diminishing tumor growth both in vitro and in vivo. Mechanistically, OTUD4 not only sustains protein stability by directly deubiquitinating GPX4 but also impedes its degradation via RHEB-mediated autophagy, collectively stalling the ferroptosis pathway. In vivo assays substantiate that OTUD4 deletion, when combined with regorafenib, drastically reduces tumor proliferation, showcasing potent synergistic antitumor activity. This study pioneers the revelation of OTUD4's bifunctional role in modulating ferroptosis through deubiquitination and autophagy, underscoring its potential as a therapeutic target in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Colorectal and Anal Disease Unit, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, No.71 Hedi Road, Nanning 530021, P.R. China; Guangxi Key Laboratory of Basic and Translational Resear…
- Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, No.71 Hedi Road, Nanning 530021, P.R. China; Department of Ultrasound, Guangxi Medical University Cancer Hospital, No.71 Hedi Road, Nanni…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Huang, C., Mei, J., Lin, Q., Chen, W., Tang, J., Wei, X., Mo, C., Zhang, Y., Zeng, Q., Mo, X., Tang, W., & Luo, T. (2025). OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115681
Vancouver
Chen J, Huang C, Mei J, Lin Q, Chen W, Tang J, et al. OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115681
BibTeX
@article{Chen2025,
author = {Chen, Jinglian and Huang, Chengqing and Mei, Jiale and Lin, Qiuhua and Chen, Wenbo and Tang, Jiali and Wei, Xinjie and Mo, Caixia and Zhang, Yueyan and Zeng, Qi and Mo, Xianwei and Tang, Weizhong and Luo, Tao},
title = {OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115681}
}
EUVIMED